Italian Life Sciences Database

News in the Life Sciences Industry
Results 101 - 120 out of 155 displayed.
« 1 2 3 4 5 6 7 8 »

Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis

By: GlobenewsWire - 17 Apr 2020

International Medical Corps and Vista Medical Center East Partner to Respond to COVID-19 Surge

WAUKEGAN, Ill., April 16, 2020 /PRNewswire/ -- As part of its global response to the COVID-19 pandemic, International Medical Corps has deployed emergency medical field units, personal protective equipment (PPE) and volunteer clinicians to Vista Medical Center East. The hospital is part of Vista... Read more ››

By: PR Newswire Association LLC. - 16 Apr 2020

Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution

By: GlobenewsWire - 16 Apr 2020

Insilico enters into a research collaboration with Boehringer Ingelheim to apply novel generative artificial intelligence system for discovery of potential therapeutic targets

HONG KONG, April 14, 2020 /PRNewswire/ -- Insilico Medicine is pleased to announce that it has entered into a research collaboration with... Read more ››

By: PR Newswire Association LLC. - 15 Apr 2020

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

By: GlobenewsWire - 14 Apr 2020

DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-2 in COVID-19 patients by the end of April 2020, allowing identification of immune response development to the virus

SALUGGIA, Italy, April 10, 2020 /PRNewswire/ -- DiaSorin (FTSE MIB: DIA) announced today the completion of the studies conducted at the Policlinico San Matteo in Pavia to support the launch of a new serological and high-processing volume test to detect the presence of antibodies in patients infected... Read more ››

By: PR Newswire Association LLC. - 11 Apr 2020

Related companies: Diasorin S.p.A.

Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years

By: GlobenewsWire - 03 Apr 2020

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

By: GlobenewsWire - 30 Mar 2020

UCB SA/NV : Convening notice to the general meeting of shareholders

By: GlobenewsWire - 27 Mar 2020

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

By: GlobenewsWire - 27 Mar 2020

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

August 2020
- ChinaBio® Partnering Forum 2020 Digital
- Biotechgate Digital Partnering Event
September 2020
- Basel: Pharma-Biotech Product & Company Valuation

See Events »

Add an Event »

Latest company news

Six-month interim report (Q2) 2020
12 Aug 2020 (GlobenewsWire)

Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at constant exchange rates (CER) in the first six months of 2020
06 Aug 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
05 Aug 2020 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis

International Medical Corps and Vista Medical Center East Partner to Respond to COVID-19 Surge

Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution

Insilico enters into a research collaboration with Boehringer Ingelheim to apply novel generative artificial intelligence system for discovery of potential therapeutic targets

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-2 in COVID-19 patients by the end of April 2020, allowing identification of immune response development to the virus

COVID-19: Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

Recordati Rare Diseases now holds Isturisa® European MA

Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron

Novo Nordisk A/S – Share repurchase programme

Sanofi successfully prices taps on outstanding bond issues for EUR 500 million

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

Sanofi: Availability of the Pre-quarterly Results Communication

Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years

SI-BONE, Inc. Provides Business Update in Response to COVID-19 Pandemic

Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020

Novo Nordisk A/S - Share repurchase programme

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

UCB SA/NV : Convening notice to the general meeting of shareholders

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news